Stockscreener 앱 받기
1.21
1.68%
0.02
Intelligent Bio Solutions Inc 주식(INBS)의 최신 뉴스
Intelligent Bio Solutions Files For Mixed Shelf Of Up To $100 MillionSEC Filing - MarketScreener
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - The Globe and Mail
Intelligent Bio Solutions (NASDAQ:INBS) Trading Up 7% – Time to Buy? - Defense World
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win - MSN
U.S. Patent Granted to Intelligent Bio Solutions for Drug Screening Tech - Medical Product Outsourcing
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System - The Manila Times
Major Market Expansion: Drug Screening Tech Now Reaches 450 Million Arabic Speakers - Stock Titan
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show - The Manila Times
Game-Changing Drug Testing Technology: Non-Invasive Solution Poised for Major US Launch - Stock Titan
MasterCard : Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - MarketScreener
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra - The Manila Times
Intelligent Bio Solutions Highlights Continued Expansion With Strategic Partnership In Spain And Andorra - MarketScreener
Major Expansion: Intelligent Bio Solutions Captures $448M Spanish Drug Testing Market with 1,000 Monthly Orders - Stock Titan
US patent granted for INBS’ fingerprint drug screening technology - Yahoo
Intelligent Bio Solutions secures new U.S. patent By Investing.com - Investing.com South Africa
Intelligent Bio Solutions Secures U.S. Patent for Drug Screening - TipRanks
Intelligent Bio Solutions secures new U.S. patent - Investing.com
Intelligent Bio Solutions Granted U.S. Patent For Fingerprinting Drug Screening Cartridge - Marketscreener.com
Revolutionary Fingerprint Drug Test Secures Game-Changing Patent for 2025 US Launch - Stock Titan
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology - Benzinga
Intelligent Bio Solutions On Track For 2025 U.S. Launch Of FDA-Cleared Fingerprint Drug Test - Nasdaq
Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch - The Manila Times
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch - TradingView
Revolutionary Drug Screening System Achieves 94% Accuracy in FDA Submission Data - Stock Titan
EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch - Benzinga
Intelligent Bio Solutions Anticipates Sixth U.S. Patent Approval - TipRanks
Intelligent Bio Solutions Expecting to Get US Patent to Enhance Protection of Lateral Flow Technology - Marketscreener.com
Intelligent Bio Solutions Inc. Announces Anticipated Sixth Patent for Lateral Flow Technology in Drug Testing Solution - Nasdaq
Intelligent Bio Solutions set to secure new US patent - Investing.com
Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant - The Manila Times
Revolutionary Fingerprint Drug Test Patent Strengthens Intelligent Bio Solutions Market Position - Stock Titan
Intelligent Bio Solutions to Offer Additional Common Stock By Investing.com - Investing.com Australia
Intelligent Bio Solutions to Offer Additional Common Stock - Investing.com
Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th - The Manila Times
Intelligent Bio Solutions Reveals Growth Strategy at Elite Investor Conference March 25 - StockTitan
Intelligent Bio Solutions closes public offering of common stock - Medical Buyer
Intelligent Bio Solutions Inc (INBS) Should Be Considered For The Next Few Weeks - Stocks Register
Navient finalizes sale of Government Services business - The Manila Times
Intelligent Bio Solutions shares fall on proposed offering of common stock - MSN
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock - The Manila Times
Intelligent Bio Solutions Inc. Closes $3 Million Public Offering of Common Stock - Nasdaq
Can This $3M Capital Raise Transform Intelligent Bio Solutions' Future? - StockTitan
Intelligent Bio Solutions announces pricing of $2.6 million public offering; shares fall - MSN
Intelligent Bio Solutions sets $2 public stock offering By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Inc. Announces $2.6 Mln Common Stock Offering Pricing - Nasdaq
Intelligent Bio Solutions sets $2 public stock offering - Investing.com
Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock - The Manila Times
Can This $2.6M Biotech Offering Signal Growth Potential for Intelligent Bio Solutions? - StockTitan
Intelligent Bio Solutions Announces Proposed Public Offering Of Common Stock -February 19, 2025 at 05:50 pm EST - Marketscreener.com
1.79%
자본화:
|
볼륨(24시간):